Published in
PLOS Medicine, Public Library of Science
Content
by Jule Bachl, Melanie Hagen, Georg Schett
Chimeric antigen receptor (CAR)-expressing cells bear a great potential for the treatment of autoimmune diseases. While numerous challenges persist, recent technological developments have demonstrated the potential for CAR cells to reset dysfunctional immune systems and transform care for patients with autoimmune disease. Chimeric antigen receptor (CAR)-expressing cells bear a great potential for the treatment of autoimmune diseases. In this Perspective, Jule Bachl, Melanie Hagen, and George Schett discuss the challenges and potential of recent technological developments for transforming care for patients with autoimmune disease.
Georg Schett
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 25
- Comments 0